Current Grants

Coverage, price, and reimbursement for multigene tests for cancer and related conditions

The objective of this award is to examine “coverage, price, and reimbursement” (“CPR”) for cancer risk multigene tests (panels and sequencing tests): what tests are covered by payers, why are tests covered or not covered, and how CPR influences testing decisions and practices in clinic settings.

Funding: NIH/NCI (R01CA221870)

Timeframe: 07/01/2018 – 06/30/2021

Summary:  PDF iconOne-pager with grant details

Genomic sequencing to aid diagnosis in pediatric and prenatal practice

The center grant will focus on generating and analyzing evidence regarding the clinical utility of genome sequencing from the perinatal period into early childhood through examining clinical utility, ethical implications, payer coverage, and data integration in a diverse population.

Funding: NIH/NHGRI (U01HG009599)

Timeframe: 08/01/2017 – 05/31/2021

Summary: PDF iconOne-pager with grant details

Prevention of Fractures in Patients with Parkinson's Disease

This parent grant will take the form of a large, home-based trial testing the hypotheses that among older patients with Parkinson’s disease a single treatment of zoledronic acid (ZA) will reduce the risk of 1) nonvertebral fractures, 2) hip fracture, and 3) all-cause mortality. TRANSPERS is leading a sub-aim as part of this study to assess the generalizability and interpretation of the economic findings and, as relevant, participate in developing a detailed cost-effectiveness analysis to support the implementation of the intervention in broader health care settings.

Funding: NIH/NIA (RO1AG059417)

Timeframe: 09/30/2018 – 02/28/2024

Summary: One-pager with grant details (pending)

Previous Grants

Risk-benefit trade-offs for whole genome sequencing

The objective of this award is to evaluate the benefit-risk trade-offs of genomic sequencing technologies from an individual perspective -how patients make decisions about sequencing and from a societal perspective - how sequencing may impact the health care system.

Funding: NHGRI (R01HG007063)

Timeframe: 02/15/2013 – 01/31/2019

Developing evidence on reimbursement for the UCSF500 tumor profiling panel test

Our objective is to collect evidence on reimbursement challenges for Cancer Tumor Profiling (UCSF500) tests and explore how those challenges could be addressed. The goal is to obtain preliminary data and develop a multi-disciplinary team of collaborators that can compete for larger grant funding.

Funding: UCSF Research Administration Program

Timeframe: 07/01/2017 – 8/15/2018